BALCX
Price
$38.33
Change
+$0.10 (+0.26%)
Updated
Sep 15 closing price
Net Assets
263.06B
MTRIX
Price
$20.12
Change
-$0.03 (-0.15%)
Updated
Sep 15 closing price
Net Assets
7.77B
Interact to see
Advertisement

BALCX vs MTRIX

Header iconBALCX vs MTRIX Comparison
Open Charts BALCX vs MTRIXBanner chart's image
American Funds American Balanced C
Price$38.33
Change+$0.10 (+0.26%)
VolumeN/A
Net Assets263.06B
MFS Total Return I
Price$20.12
Change-$0.03 (-0.15%)
VolumeN/A
Net Assets7.77B
BALCX vs MTRIX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
BALCX vs. MTRIX commentary
Sep 16, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BALCX is a Buy and MTRIX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
BALCX has more cash in the bank: 263B vs. MTRIX (7.77B). MTRIX pays higher dividends than BALCX: MTRIX (2.52) vs BALCX (1.16). BALCX was incepted earlier than MTRIX: BALCX (25 years) vs MTRIX (29 years). BALCX (1.31) is less costly to investors than MTRIX (0.47). MTRIX is a more actively managed with annual turnover of: 53.00 vs. BALCX (44.00). MTRIX has a lower initial minimum investment than BALCX: MTRIX (0) vs BALCX (250). BALCX annual gain was more profitable for investors over the last year : 9.16 vs. MTRIX (1.55). BALCX return over 5 years is better than : 37.96 vs. MTRIX (14.00).
BALCXMTRIXBALCX / MTRIX
Total Expense Ratio1.310.47279%
Annual Report Gross Expense Ratio1.310.47279%
Fund Existence25 years29 years-
Gain YTD12.8678.539151%
Front LoadN/AN/A-
Min. Initial Investment2500-
Min. Initial Investment IRAN/AN/A-
Net Assets263B7.77B3,383%
Annual Yield % from dividends1.162.5246%
Returns for 1 year9.161.55591%
Returns for 3 years40.6215.74258%
Returns for 5 years37.9614.00271%
Returns for 10 years71.7244.11163%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
DOC18.250.17
+0.94%
Healthpeak Properties
RDHL1.50-0.01
-0.66%
Redhill Biopharma Ltd
LE15.47-0.11
-0.71%
Lands' End
OCUL12.54-0.27
-2.11%
Ocular Therapeutix
STTK1.79-0.13
-6.77%
Shattuck Labs